Biotech Breakthrough: Pioneering Organ 'Sacks' to Revolutionize Medical Research

A billionaire-backed startup, R3 Bio, is developing genetically-engineered organ systems to replace animal testing. This groundbreaking approach aims to create human-like organs for safer, more ethical medical research.
In a remarkable breakthrough for the medical research industry, a billionaire-backed startup called R3 Bio is pioneering the development of genetically-engineered organ systems that could revolutionize the way new drugs and treatments are tested. Rather than relying on animal testing, which has long been criticized for its ethical and scientific limitations, R3 Bio is working to create what they call
Source: Wired


